VARUBY provides protection for delayed chemotherapy-induced nausea and vomiting (CINV) with a single dose ...
SOUTH JORDAN, Utah, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: ...
*Results from full 24 weeks of dosing from the first three cohorts of the ...
